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The growing concern regarding emergence of bacteria resistant to antimicrobials
and their potential for transmission to humans via animal production has led various
authorities worldwide to implement measures to decrease antimicrobial use (AMU) in
livestock production. These measures are influenced by those implemented in human
medicine, and emphasize the importance of antimicrobial stewardship, surveillance,
infection prevention and control and research. In food producing animals, unlike human
medicine, antimicrobials are used to control diseases which cause economic losses.
This major difference may explain the failure of the public policies implemented to
control antimicrobial usage. Here we first review the specific factors influencing AMU
across the farm animal sector and highlighting the farmers’ decision-making process
of AMU. We then discuss the efficiency of existing regulations implemented by policy
makers, and assess the need for alternative strategies, such as substitution between
antimicrobials and other measures for infectious disease control. We also discuss the
interests of regulating antimicrobial prices. Finally, we emphasize the value of optimizing
antimicrobial regimens, and developing veterinary precision medicine to achieve clinical
efficacy in animals while limiting negative impacts on public health. The fight against
antimicrobial resistance requires both a reduction and an optimization of antimicrobial
consumption. The set of actions currently implemented by policy makers does not
adequately address the economic interests of farmers’ use of antimicrobials.
Keywords: antimicrobials, antimicrobial resistance, veterinary precision medicine, public policies, livestock
production, agricultural economics
INTRODUCTION
Since the discovery of sulfonamides in 1932, antimicrobials have been used across the human and
animal health sectors to cure infectious diseases. The global rising demand for animal protein for
human feeding will potentially lead to a massive increase in AMU in food-animal production,
estimated to rise by 67% between 2010 and 2030. However, because of differences between national
Abbreviations: AMR, antimicrobial resistance; AMU, antimicrobial use; CIA, critically important antimicrobials; PK/PD,
pharmacokinetics/pharmacodynamics.
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regulatory frameworks surrounding antimicrobial sales, there
are only limited data regarding AMU, particularly in low-
and middle- incomes countries (Van Boeckel et al., 2015). In
2012, 26 European Union countries’ average consumption of
antimicrobials was respectively 116.4 and 144.0 milligrams per
kilogram of estimated biomass in humans and animals (European
Centre for Disease Prevention, and Control [ECDC]/European
Food Safety Authority [EFSA]/European Medicines Agenc
[EMA], 2015). As in human medicine, AMU in veterinary
medicine, even when rational, might lead to the selection of
genetic material encoding for bacterial resistance. The selection of
resistant bacteria, zoonotic pathogens or commensals represents
a particular public health hazard as it can be transferred to
humans via direct contact or indirectly via the food chain
(Aarestrup and Wegener, 1999; Singer et al., 2003).
The quantitative impact of AMU in veterinary medicine on
public health remains difficult to assess (Singer and Williams-
Nguyen, 2014). However, based on its potential impact, most
countries from Northern Europe implemented specific plans to
decrease AMU in veterinary medicine. The practical measures
adopted are very similar to those observed in human medicine.
They rely on general concepts on the control of AMU; four
topics are systematically involved, among others: (i) stewardship,
(ii) surveillance, (iii) infection prevention and control and (iv)
research. The interests of such measures have been widely
documented in human health (Edwards and Gould, 2012;
Premanandh et al., 2016). In accordance with the One Health
concept, the importance of controlling AMU in the animal
sector has also been highlighted (Dar et al., 2016; Premanandh
et al., 2016). Prescription of antimicrobials in companion animals
basically follows an individual diagnosis of illness. In food animal
production, antimicrobials are used in three different situations:
(i) curative treatment of diseased animals, (ii) metaphylactic
treatment of a group of animals, meaning treatment of diseased
and healthy animals belonging to the same group in case of high
risk of contagious disease, and (iii) prophylactic treatment of a
group of healthy animals, considered at high risk of developing
the disease in the case of no prophylaxy. Since the quantities
of antimicrobials used in companion animal medicine are very
low compared to those used in the overall animal sector, farm
animals are recognized as the main source regarding AMR. As
such, companion animals will not be further considered in the
present study.
Since the ban of antimicrobials as growth promoters in
the European Union in 2003, followed by the USA in 2015,
various sets of measures regarding AMU have been implemented
in veterinary medicine, generally mixing regulations and
voluntary approaches (European Union, 2003; Food and Drug
Administration, 2015). These measures have led to spectacular
decreases in antimicrobial consumption. For example, a 58.1%
decrease in antimicrobial consumption in food producing
animals was observed between 2009 and 2014 in the Netherlands
(MARAN, 2015). In France, the global exposure to antimicrobials
in veterinary medicine decreased by 15.7% between 2007 and
2013 (Chevance and Moulin, 2014).
Yet, these results hide large differences among species,
administration route and classes. For instance, in the Netherlands
in 2014, the veterinary sales of penicillins, third and fourth
generation cephalosporins, fluoroquinolones, amphenicols and
macrolides and lincosamides increased by 10, 4.3, 2.4, 18,
and 12%, respectively, in spite of a massive decrease of
these classes in the previous years; in the meantime, sales
of tetracyclines, trimethoprim/sulphonamides, pleuromutilins,
polymyxins and aminoglycosides dropped (MARAN, 2015).
In France, between 2007 and 2013, veterinary prescription of
antimicrobials administered per oral route decreased by 24%
whereas prescription of parenteral antimicrobials increased by
9%. The exposure decreased by 28, 10, 13% in pigs, companion
animals and poultry, respectively, but slightly increased (+0.2%)
in cattle (Chevance and Moulin, 2014). Altogether, these
observations show that the decrease in AMU is multifactorial
and follows complex and various steps and ways. Therefore,
the risk that the above mentioned policies fail to tackle AMR
is high, as has been suggested in human health (Wallinga
et al., 2015). Furthermore, as several measures are implemented
simultaneously, the evaluation of their individual impact remains
challenging.
The aims of this study are to provide an overview of identified
factors influencing AMU across the farm animal sector, to discuss
the effectiveness of existing measures minimizing AMR, to
evaluate the possibilities of substitution between antimicrobials
and other production factors, and to discuss the need to develop
research programs to optimize antimicrobial efficiency in a One
Health perspective.
FACTORS INFLUENCING
ANTIMICROBIAL USE: THE CRUCIAL
ISSUE OF FARMER’S DECISION MAKING
Occurrence of Infectious Diseases and
Pathogen Expression at the Farm Level
Most infectious diseases occur in cases of simultaneous presence
of an infectious agent and a susceptible host, the latter being
influenced by exogenous and endogenous risk factors (Figure 1,
blue circles). Exogenous risk factors are imposed on farmers; they
have little, if any, control over them. Pathogens and their regional
prevalence, climate or general factors such as changes in markets
represent exogenous factors of infectious diseases. For example,
respiratory infections affecting young cattle are more frequent
in winter (Cernicchiaro et al., 2012). These factors directly
contribute to the basal level of infectious diseases observed in
a given production system (Raboisson et al., 2012). Similarly, a
basal level of antimicrobials is used in each given production
system, almost proportionally to the basal level of infectious
disease.
The basal level of infectious disease (and its associated
AMU) is the direct result of the expression of exogenous risk
factors. This level can be defined considering a good (perfect)
management of the farmer facing these –changing– exogenous
factors. Because the production systems are complex and farmer
decisions are not always optimal (see below), a suprabasal
level of infectious disease and AMU is often considered as
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FIGURE 1 | Factors influencing antimicrobial use in food-animal production, and priority actions preventing their suboptimal use.
being acceptable by professionals. This level represents the
health convention (or health standards) of the given livestock
system (Raboisson, 2011), meaning an accepted or approved
target against which others are judged or measured. The health
convention for a given livestock system considers at least a health
standard for diseases occurrence and a health standard for AMU.
Many farms do not reach these health standards, mainly due to
endogenous factors.
The endogenous risk factors of infectious disease relate
directly to the decisions of farmers who can control them. They
include how the farmer adapts to the exogenous risk factors of a
given system as well as how he reacts to the occurrence of disease.
These two topics represent the preventive and curative aspects
of the disease management. Both aspects are the quintessence
of a farmer’s role in AMU. For instance, animal nutritional
status, housing and raising conditions, feed quality and quantity,
and choice of breed are examples of endogenous factors. Poor
decision making in regards to endogenous risk factors such as
the absence of quarantine, having a shared air space for several
groups of calves, and the lack of clinical examination upon arrival
at the farm may lead to development of respiratory diseases
which have also been associated with increased incidence of
antimicrobial treatments (Lava et al., 2016).
Interestingly, most endogenous risk factors are, and behave
as, production factors. This means that variations in these
endogenous and production factors affect both the quantity of
produced foodstuffs (outputs) such as milk or meat and the risk
of disease occurrence. For example, implementing quarantine
requires extra pens that will (hopefully) only be used a small part
of the time. Their presence decreases the risk of disease in the
herd. In the absence of disease, these extra pens are unnecessary
production factors, which decrease the overall benefit to the
farmer.
At the farm level, the farmer holds a key position, with a dual
role of decision maker and risk factor per se. The farmer’s choices
in the herd management will therefore directly and indirectly
influence the disease occurrence and consequently AMU.
On Farm Factors Influencing the
Farmer’s Attitude toward Disease
The occurrence but also the threat of infectious disease (see
below) represents the first step conditioning the implementation
of an antimicrobial treatment. Considering this occurrence,
the farmer establishes a response influenced by farm factors
(Figure 1, purple boxes and circle), under a given institutional
context (Figure 1, golden boxes). The farmer’s decision making
is primarily influenced by three components: (i) the cost-benefit
analysis of the treatment for the disease, (ii) the farmer’s expertise,
attitude toward risk, and behavior, and (iii) his/her ability to
detect the disease.
Cost-Benefit Analysis
Antimicrobials are used to cure infectious diseases in both human
and veterinary medicine. In addition to the shared therapeutic
objective, AMU also achieves in veterinary medicine an economic
objective through the optimization of the farm benefits.
Depending on the characteristics of the diseases (infectiousness,
morbidity, lethality) and their consequences (individual, local,
global level), the losses associated vary massively. As an example
of highly and fast contagious disease, Pendell et al. (2015) assessed
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the costs of a hypothetic outbreak of Foot and Mouth Disease
in the United States, ranging from $16 to $140 billion. On
the other hand, the costs of clinical mastitis generally affect
only the aﬄicted herd, representing roughly a cost of $224 to
$275 per case (Steeneveld et al., 2011). Many assessments of
losses or total cost of diseases exist but few clearly evaluate
the profitability of different strategies of management including
use of antimicrobials as curative or preventive treatment.
Nevertheless, in spite of formal demonstration, the comparison
between the price of antimicrobials and the cost of diseases
suggest a highly profitable use of antimicrobials for many of the
diseases (but probably not all), at least in first intention therapy.
Food animal production is an economic process where the
farmer’s first goal is animal foodstuffs trading. In this production
process, disease occurrence appears as damage, and recourse
to antimicrobials tends to limit the losses generated by the
disease. Therefore, the farmer may consider antimicrobials as
a production factor, and the decision to use antimicrobials
may be based on the expected financial return associated with
the treatment. The profitability associated with the use of
antimicrobials is based on the cost of the treatment and on
the expected return associated with damage control (Tisdell,
1995). The control of the damage becomes an economic process,
in which the antimicrobial treatments generate an additional
output at least equivalent to saved losses (compared to no
treatment). The economic rationality should lead the farmer
to use antimicrobials only when profitable. In cases of diseases
already present, the choice is made regarding the expected saved
losses (depending on expected antimicrobial efficacy and on
the extended impact of the disease, i.e., severity, risk of spread
of disease or mortality without treatment) and the price of
the treatment. In addition to these items, the implementation
of a preventive treatment is also based on the probability of
occurrence of the disease in the future. This means that the
price of antimicrobials represents a key component of AMU,
for both prevention and curative treatments. In many countries,
the high efficacy of antimicrobials and their relatively low cost
make their use favorable. To sum up, for a given livestock system
and a given disease, an economic optimum of disease control
is defined as a function of the level of threat of the disease in
absence of treatment, the risk of being infected/ill, the expected
efficacy of the therapy and the cost of veterinary service. The
value of the production (outputs) is also a factor influencing
AMU since the higher the price of the output, the higher the
economic impact of the disease in the case of no treatment.
AMU is sensitive to the antimicrobial price. A decrease in the
price of antimicrobials, which occurred with the introduction
of fluoroquinolone generics on the French market, was for
instance associated with a significant increase in the amount
of fluoroquinolones consumed in poultry production (Chevance
and Moulin, 2009).
Farmer’s Expertise, Attitude toward Risk, and
Behaviors
During the decision-making process, the farmer balances the cost
of antimicrobials with the expected benefits of the treatment. This
refers to the “perceived benefits” developed in the 1950’s in the
Health Belief Model to understand behaviors of patients’ response
to a disease (Rosenstock, 1974). When facing a threat, the farmer
decides to use one antimicrobial according to his/her perception
of efficacy, based on regulatory guarantees such as market
authorization, but also based on his/her own beliefs (Grein,
2012). Farmers’ choices were shown to be strongly influenced
by personal beliefs and perceptions (Hadar and Fischer, 2008;
Kristensen and Jakobsen, 2011). When facing a given disease
threat, the farmer subjectively evaluates the potential impact of
the disease in cases of no treatment and the net return. Before
any administration of preventive treatment (with antimicrobials
or not) in the presence of risk factors of disease, the farmer
subjectively evaluates (i) the real risk of disease occurrence, (ii)
the potential impact of the disease in case it occurs and (iii) the
technical possibilities of curative treatment if disease occurs. All
these evaluations vary according to his/her technical expertise
(knowledge and skills), his/her attitude toward risk and his/her
behaviors.
Technical expertise was reported to be associated with age,
education level and level of antimicrobial consumption. Danish
pig farmers with less than 4 years of practical experience
detected clinical diarrhea more accurately than farmers with
more than 4 years of practical experience (Pedersen and Strunz,
2013). Similarly, young Belgian farmers were more likely to
implement biosecurity measures in their herd, leading to a
decrease in antimicrobial consumption (Laanen et al., 2013).
The farmers’ age was likely to be a proxy for recent education.
Low education and poor knowledge of farmers regarding AMU
were associated with increased AMR and zoonotic infections in
a Sudan study (Eltayb et al., 2012). Both herd characteristics
and farm management impact the level of AMU, and explain
heterogeneity within farms: for instance, 25% of the French
poultry herds consumed between one and two thirds of the total
antimicrobial amount (Chauvin et al., 2012).
A farmer’s risk aversion also leads to higher AMU, when the
farmer expects a decreased risk in the production system as he
uses antimicrobials. Risk aversion is particularly observed during
peculiar stress or economic crisis. The farmer seeks to secure
his/her income while avoiding a major epidemic, even if his/her
income (decreased by additional antimicrobial costs) remains
lower than the optimal one. Such behaviors have been described
in a survey conducted in rabbit production, showing a negative
correlation between income level and AMU (Chauvin et al.,
2011). The influence of attitude toward risk was also evidenced
in beef cattle farmers facing climatic hazard or decrease in meat
prices (Mosnier, 2009). Since respiratory diseases are the key
disorder in this line of production, beef farmers with a strong
risk aversion are more likely using antimicrobials –including
for prevention– limiting the probability of a massive respiratory
outbreak.
Farmer’s behaviors are also influenced by non-economic
factors, such as values and motivations. The farmer’s decisions
to follow (or not) the recommendations can partially be
explained through social sciences and the different categories
of farmers (Garforth, 2015). A recent study conducted on
sheep farmers’ response to foot rot focused on the effects of
personality, emotions such as empathy and general attitude on
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the treatment strategy. The authors found that sheep had an
increased risk of lameness when their farmers demonstrated
negative emotions and hopelessness toward foot rot, and
that farmers’ personality and emotions are associated with
their differences in management of foot rot (O’Kane et al.,
2016).
Disease Appraisal
Disease diagnosis relies on a combination of farmers’ knowledge
and available diagnostic tools. A major difference from
human medicine is that antimicrobial therapy is often
implemented empirically, based upon the concurrent presence
of epidemiological and clinical factors, and rarely involves
laboratory testing confirming the presence of bacterial infection.
Availability and cost of tests at the animals’ side seem to limit
their use, particularly when the results of these tests cannot
be extrapolated to the entire herd and may also need to be
frequently repeated (Speksnijder et al., 2015a). The moderate
costs of treatment – including antimicrobials – also limit the
use of tests before treatment. For individual animal treatment
(internal medicine), additional costs of laboratory testing
substantially increase the total costs of disease treatment
supported by the farmers, and therefore probabilistic therapeutic
approaches are common. In population medicine, the use of tests
is more frequent since their marginal costs are decreased.
Absence of specific and sensitive tests is not rare for food
producing animal diseases. As an example, absence of a specific
field diagnostic test for bovine respiratory disease has been
reported as a limitation in diagnosing cattle and might lead to
an overconsumption of antimicrobials to prevent the appearance
of infection (Taylor et al., 2010).
Institutional Influences
Decision making also depends on institutional influences, such as
technical environment, regulations and food chain organization
(Figure 1, golden boxes).
In several European countries, voluntary and regulatory
actions were implemented by policy makers, involving farmers’
health management associations and the veterinary profession.
Several European countries decided on a ban of the preventive
use of CIAs. Complementary mandatory measures were
implemented, including the use of susceptibility testing
before any prescription of CIA for curative purposes. To
avoid competition among veterinary practices and therefore
potential pressure in antimicrobial prescription and to promote
farmer-veterinary relationships and farmer’s education, Dutch
farmers were asked by the government to choose only one
veterinary practice to provide oversight and prescription
in their herds (Speksnijder et al., 2015b). In France, a
“Plan Ecoantibio” program was initiated in 2012 and lasts
until 2017. This is a voluntary approach program fixing
an objective of a 25% decrease in AMU. It is coordinated
by the government and emphasizes farmers’ stewardship
(Lhermie et al., 2015). In France, the United Kingdom,
the Netherlands and Belgium, treatment guidelines were
developed, supporting veterinarians in their therapeutic
decision-making.
The decision making of the farmer also depends on access
to antimicrobials (Figure 1, orange boxes). In most high-
income countries, veterinary antimicrobial delivery is submitted
to a regulated system, involving prescribers (veterinarians) and
suppliers (veterinarians, pharmacists, others). The regulations
surrounding antimicrobial prescription and delivery should
theoretically ensure their strict usage and limit unjustified
consumption from a medical point of view. The question
of the influence of farmers on veterinarian’s prescription is
poorly known, but certainly not dissimilar from the influence
of patients on their physicians, which has already been
reported (Avorn and Solomon, 2000; Orzech and Nichter,
2008).
For certain antimicrobial classes such as CIA, policies were
implemented to ban or limit their use in animal health
(Collignon et al., 2009). However, in many low-income countries,
weakly or poorly regulated practices surrounding manufacturing
and access to drugs might encourage inappropriate use
and therefore reduce stewardship (Dar et al., 2016). In
countries with weak regulations, it has been shown that a
major part of the sales were performed over the counter,
resulting in potential incorrect dosages and non-observance
of withdrawal periods (Shryock, 2012). Lastly, they increase
the possibilities of counterfeit drugs, without guarantee of
efficacy.
People outside the farm and more broadly the farm network
(so-called institutional context of the farm) may also influence
AMU. Discrepancies in AMU were observed in cattle feedlots,
depending on clinical circumstances and on actors in the
feedlot network (McIntosh and Dean, 2015). The influence
of the social network and citizenship behavior has also been
reported to influence decisions in a survey focused on farmers’
attitudes toward BVD control in the UK (Heffernan et al.,
2016).
Consumers have already started to indirectly influence
food animal production systems and their associated AMU.
In high-income countries, the growing demand of foodstuffs
produced respecting environmental, animal welfare and
public health issues has become a strong driver of AMU
decrease. Consumers’ impact is likely to grow, including strict
antimicrobial restrictions in animal production. For instance,
McDonalds’ USA recently announced that the goal set in 2015
to “only serve chicken not treated with antibiotics important
to human medicine” was achieved in July 2016 (McDonalds’,
2016).
The question of the potential conflict of interests for
veterinarians as both prescribers and suppliers has been recently
addressed (Rosbach, 2012). France and the Netherlands decided
to maintain this dual status for veterinarians (Dahan, 2013). The
Danish government implemented advisory roles to compensate
veterinarians for income loss due to removing their status
as suppliers (Dar et al., 2016). To our knowledge, no study
has assessed the influence of the veterinary pharmaceutical
industry on veterinarians’ and farmers’ attitudes. In human
medicine, interactions between industry and physicians have
already been described Spurling et al. (2010), and Austad et al.
(2011).
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PRIORITY ACTIONS TO MINIMIZE THE
IMPACT OF VETERINARY
ANTIMICROBIAL USE ON PUBLIC
HEALTH
Tackling AMR relies on a set of measures that have been
widely reviewed Jarlier et al. (2012). Priority actions include
strengthening industrial and academic research, regulation of the
antimicrobial market, surveillance of the use, and improvement
of awareness and education of healthworkers, farm personnel
and the public. However, the specificity of use of antimicrobials
as production factors in food animal production suggests that
substitution between antimicrobials and other production factors
have to be considered. Green and blue rectangles in the Figure 1
represent the different priority actions.
Substitution between Antimicrobials and
Non-medical or Preventive Tools
Substitutions between antimicrobials and other items are likely
to represent the most important leverage of decrease in AMU
in veterinary medicine. The substitution can take place for
curative or preventive treatments and should be seen as short
or long term, meaning for the current or future production
cycles. Substitutions are based on the endogenous risk factors of
infectious disease and of AMU, previously defined as production
factors taking place in an economic process. In other words, the
economic substitution between AMU and another practice could
be economically perfect and even be financially in favor of the
non-antimicrobial practice.
In the case of declared disease, antimicrobials remain
an efficient damage control tool, with few possibilities of
substitution. Therefore, the overall antimicrobial demand is
highly rigid. The antimicrobial consumption may be limited by
early diagnosis of disease to limit the contagion to the whole
herd or group. The demand for a given antimicrobial is not
totally rigid since a substitution exists between different classes of
antimicrobials. For many diseases, the cost-benefit ratios –based
on low cost, easy-to-use and high efficacy– are in favor of the new
generations of antimicrobials even in first intent, although older
classes may be “sufficient.”
The difficulties in estimating the economic value of livestock
and the volatility of output prices and production factors limit
non-medical alternatives, even if these appear societally more
relevant, given the public health negative externality associated
with AMU.
For each situation with a possible substitution, the question
of its economic interest remains to be asked. The substitutability
among production factors encourages the use of inputs with fast
return on investments such as antimicrobials, whose effectiveness
is guaranteed under standardized conditions and which secures
farmers’ income. In addition, antimicrobials remain an easy-to-
use short-term damage control tool, whereas many other factors
exhibit their efficiency over a longer time frame. This is all the
more true for last generations of antimicrobials.
In the case of a preventive approach, the substitution between
preventive antimicrobial and preventive non-antimicrobial
(vaccine) or other non-health factors of production (food,
housing) can be easily considered. The application of good
rearing practices and higher biosecurity, i.e., changing clothes
and shoes before entering a facility, was found to be associated
with lower antimicrobial consumption in pigs (Chauvin et al.,
2005a; Laanen et al., 2013). Similarly, vaccination of calves at
arrival –or better yet, before arrival– reduces the number of
curative treatments of respiratory diseases of young cattle (Assie
et al., 2009).
Finally, the substitution between antimicrobials and other
production factors requires anticipation of risk of the health
event, based on disease prevalence and presence of endogenous
and exogenous factors. The farmer has to pick one out of
two strategies considering equilibrium between the costs of
treatments and the costs of losses. In the preventive approach,
the costs of treatments are known (the number of animals
to treat and the costs of drugs). In the curative approach,
there remains uncertainty regarding both costs of treatments
and costs of losses; if the disease does not occur, the farmer
maximizes his/her profit since no animals require a treatment,
but in the case of disease occurrence, it is likely that global
costs of disease are higher than costs of a preventive approach.
Depending on the epidemiologic form of the disease (epidemic
or endemic), and therefore its consequences in the future,
the strategies can vary: short term, high losses associated
with a disease outbreak should lead the farmer to favor a
preventive approach, whereas long term or losses spread out over
time associated with endemic diseases could lead to a passive
strategy.
At the farm level, budgetary constraints lead to allocations
of monetary resources to highly profitable strategies of disease
control. These constraints limit farmers’ investments (even more
profitable in the long term) and increase a little more their
antimicrobial demand. Lastly, even if antimicrobials do not
provide any return on investment in the absence of future disease,
their technical effectiveness easily secures the production process
productivity. Hence, they remain powerful damage control tools,
highly resistant to budget constraints.
To address this issue, future research is needed to assess
the impact of alternative strategies using fewer antimicrobials.
Economic evaluation of infectious disease management reducing
AMU, at both herd and societal levels, should be performed
over time, to consider mid-range and long term benefits.
Given the interdependence among production factors and
among farmers, health workers, retailers and regulators,
approaches merging biology, social sciences, and modeling allow
consideration of the complexity of the whole system (Grohn,
2015).
Awareness and Education
Regarding the importance of a farmer’s knowledge in the
decision making process, one can assume that all the measures
implemented to raise awareness and responsible AMU should
be encouraged, although little evidence of the benefit of such
measures in veterinary medicine exists.
Improvement of education and awareness can be attained by
proximity technical transfer or as part of coordinated actions.
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These two methods are based on the constant interactions
between farmers and organizations – public or private – playing
a role in health care (Chilonda and Van Huylenbroeck, 2001;
Raboisson et al., 2012). The major influence of veterinarians on
farmers’ AMU has been reported in several papers (Kaneene
and Miller, 1992; Chauvin et al., 2005b; McIntosh and Dean,
2015; Speksnijder et al., 2015a). In some cases, institutions can
coordinate collective action to face a collective problem (Ostrom,
1990). In human medicine, for example, consumer awareness
through communication campaigns coordinated by the French
government (campaign “Antibiotics are not automatic”) led to
a decrease in volumes of antibiotics consumed (Sabuncu et al.,
2009). Educating practitioners in small groups led by an expert
also results in a significant reduction of drug consumption
(Madridejos-Mora et al., 2004; Ranji et al., 2008). Conversely,
wide diffusion of treatment guidelines appears to produce
less tangible results (Faryna et al., 1987; Al-Momany et al.,
2009).
The success of campaigns seems to rely on their adaptation
to local conditions, the existence of a network, and support
from governmental and professional institutions (Huttner et al.,
2014). In Mexico, a bottom–up approach developing a national
strategy to fight AMR partially failed, because of a lack of
regulatory support (Zaidi et al., 2015). Hence, such strategies
might not be adequate in low-income countries (Diazgranados
et al., 2008).
In the animal health sector, research documenting the
impacts of the implemented measures is lacking and should be
encouraged, in addition to the national monitoring programs
of antimicrobial consumption which depict the global trends
in antimicrobial consumption. Furthermore, recent research
suggests that a deep understanding of the decision making
process is needed, as it can explain success or failure of policy
interventions (Rat-Aspert and Fourichon, 2010; Garforth, 2015;
O’Kane et al., 2016).
Regulations
Across countries, organization of the veterinary drug delivery
system varies. Therefore, governments have implemented specific
measures in accordance with their local scheme. Denmark, the
Netherlands and France have implemented restrictive measures
on usage of CIA, leading to a massive decrease in consumption
of these targeted antimicrobial classes (Aarestrup, 2012; Grohn,
2015; Lhermie et al., 2015; Speksnijder et al., 2015a). However,
the impact of such restrictions on misuse or overconsumption is
questionable. Indeed, for a given condition, it is likely that a CIA
will be substituted by a non-CIA, which ultimately (i) will not
decrease exposure of animals to antimicrobials, and (ii) will have
only little effect on the externality [AMR of commensal bacteria,
due to the existence of cross-resistance between the different
classes (Carattoli, 2009)].
Regulation of antimicrobial sales prices has been surprisingly
understudied. To our knowledge, sales prices are generally not
regulated. Given the principle of cost/benefit to the farmer and
the close relationship between antimicrobial cost and usage,
discussed earlier, setting high prices to antimicrobials may
certainly help limit overconsumption.
Financial Alternatives to Prices’ Control:
Taxes and Insurances
A first alternative to prices’ control consists of setting a tax
on antimicrobial sales, on the basis of costs developments
supported by pharmaceutical industries (Vagsholm and Hojgard,
2010). A Pigovian tax system could also be implemented
(Pigou, 1920). Its implementation nevertheless requires a
quantitative evaluation of the costs of AMR associated with
AMU. The complex evaluation of these costs might be a
factor explaining that the countries introducing taxes in
their set of measures chose to tax consumers. In Denmark,
a range of differentiated taxes on antimicrobials have been
applied since 2013 in order to promote the use of vaccines
instead of antimicrobials with a specific focus on CIA. The
tax rates vary between drugs: 0% for vaccines, 0.8% for
narrow-spectrum penicillins and other veterinary medicines,
5.5% for other veterinary antimicrobials and 10.8% for CIA.
However, a recent report mentioned that even if the taxes
generated fund financing activities on AMR, they did not greatly
affect antimicrobial consumption (European Commission,
2016).
Since June 2014, Belgium has implemented taxes on all
antimicrobials sold for use in veterinary medicine. The amount is
calculated as a function of the total quantity of active ingredient
(1.75€/kg), with an increase of 1.5 fold for CIA (European
Commission, 2015).
Increasing antimicrobials prices with taxes may provide
interesting changes in the case of preventive AMU, based on
substitution principles. Yet, such alternatives in the case of
curative AMU may have limited effects. Given the need for
antimicrobials to limit economic losses, it is likely that in the
context of curative individual usage of antimicrobials, a higher
cost does not lead to a significant decrease in AMU. In this
context, demand for antimicrobial remains rigid at their current
average prices.
Another alternative consists of the development of insurance
policies. Infectious diseases generate production risks, which
can be covered by insurance fewer than two conditions:
independence of risks and symmetry of information. In animal
production, the literature remains sparse compared to that
of crop production. Among the several insurance options,
income insurance is reported to be potentially more attractive
to farmers than other forms of insurance (e.g., yield, price),
because it deals with losses affecting the farmer’s welfare more
directly (Meuwissen et al., 1999). The insurance premium
could rely on net farm revenues. However, insurance of
individual income risks raises problems of moral hazard and
adverse selection. As described above, potential losses associated
with infectious diseases are explained by exogenous but also
endogenous risk factors, the latter being influenced by the
choices of the farmer, which can be different in the case
of insurance subscription. Furthermore, income can be easily
manipulated in the farmer’s balance sheet. These two factors
make the calculation of the probability distribution of a threat
and therefore the establishment of the insurance premium
complex.
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Surveillance of AMU and AMR
Surveillance represents a key component of the control of AMR
(Premanandh et al., 2016). The World Health Organization
developed standards to detect emergence of resistance. In parallel,
several countries implemented monitoring of resistance among
commensal and zoonotic bacteria. These measures should be
associated with the monitoring of antimicrobial consumption.
Harmonization of the methods of collecting data is in progress
in Europe, as comparison between countries could be a major
driver for change (Dar et al., 2016). In low-income countries,
monitoring of antimicrobial consumption and resistance is rare
and international organizations have a major role to play to
address these issues (Aidara-Kane, 2012).
Research and Innovation
Optimizing Actual Treatments
It is very likely that new antimicrobial drugs will be restricted
to human medicine (Jorgensen et al., 2016). Hence research
in veterinary antimicrobial therapy should be performed to
optimize dosage regimen of existing drugs, as functions of
the targeted bacteria, host species, and according to PK/PD
considerations. Re-evaluation of antimicrobial dosage regimens,
considering updated PK/PD requirements, constitutes a first
step to limit the impact of antimicrobials on commensal floras.
For example, recently in veterinary medicine, the marbofloxacin
dosage regimen was re-evaluated for treatment of Gram negative
infections and the current labeled dose of 10 mg/kg given in
a single injection was added to the first label approved dosage
of 2 mg/kg over 3–5 days, leading to a decrease in the time
of residence of the drug in the body while maintaining clinical
efficacy (Valle et al., 2012). Dosage regimens of existing drugs
previously determined according to results of clinical trials
can also be evaluated based on standard PK/PD concepts, as
performed with tulathromycin in calves (Toutain et al., 2016b).
Innovations in veterinary AMU should also aim to limit the
impact of antimicrobials on the commensal flora (especially
the digestive flora) of the treated animals, without reducing
their curative efficacy on the targeted bacterial infection.
A recent review depicted the PK/PD characteristics of the
ideal antimicrobial for food-producing animals (Toutain et al.,
2016a). This antimicrobial should be administered orally,
and antimicrobials with a high bioavailability, with limited
interactions with compounds of the digestive tract, should
be preferred. In the case of parenteral administration, long-
acting compounds with a low clearance, ensuring long half-life
elimination, or long-acting formulations limiting the impact on
the digestive flora, are recommended.
Veterinary Precision Medicine
In human medicine, Personalized Medicine is defined as a
form of medicine built on information about patients’ genes
and their environment, aiming to refine diagnosis, to select
the most appropriate treatment and increase the patient’s
chances of recovery (Feero and Guttmacher, 2014; Peer, 2014).
In parallel, Precision Agriculture emerged in the late 20th
century, fulfilling an objective of optimization of agricultural
practices while considering their environmental impacts
(McBratney et al., 2005). In crop science, digital technologies
(satellite mapping, climate and epidemic alarm systems) provide
farmers tools for supporting decision making. These tools allow
for example, limitation of consumption of fertilizers or pesticides.
In animal production, precision farming is defined as “the use of
technology for monitoring physiological indicators, behavioral or
production on animals to improve herd management strategies
and breeding performance” (Bewley, 2010).
Veterinary precision medicine, which we can define as an
optimized preventive or curative therapeutic approach (right
animal, right drug, right dose, right time) based on identification
of biomarkers of disease and use of technologies of disease
monitoring, may provide strong leverage of AMU rationalization.
It relies on availability of diagnostic tools allowing one to quickly
identify the pathogen and the bacterial load.
In field conditions, the lack of cheap and practical
diagnostic tools constitutes a major barrier to rationalization of
antimicrobial treatment, and innovation in this domain should
be firmly encouraged. Optimization of the antimicrobial regimen
can also be achieved by combining early detection of disease
with a low antibiotic usage regimen. New techniques of bovine
respiratory diseases diagnostics, such as cough captors or ruminal
temperature boluses, can be used to monitor early signs of illness
before appearance of clinical signs (Timsit et al., 2011a,b).
Recent studies conducted with mice and calves suggested that a
decrease in the administered dose of fluoroquinolone allowed
achievement of similar bacterial cure, when low bacterial inocula
are targeted and the disease is detected early (Ferran et al., 2011;
Lhermie et al., 2016). These protocols significantly decrease the
amount of antibiotic required to reach a similar clinical efficacy.
CONCLUSION AND PROSPECTS
The fight against AMR requires reduction and optimization
of antimicrobial consumption. The set of measures currently
implemented overlooks the economic interests of farmers
regarding their use of antimicrobials. The objectives of usage
decrease targeted by policy makers remain a signal of importance
of the AMR issue, but do not influence individual choices.
Priority actions encouraging sustainable AMU, considering both
societal issues and farmers’ constraints, should be targeted.
Exploring the interests of alternatives and possibilities of
optimization of AMU should be encouraged. In parallel, the
development of initial and postgraduate education programs of
farmers and health workers regarding antimicrobial stewardship,
as well as an evaluation of the benefits of such measures, should
be conducted.
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